Hbot denied as experimental or investigational by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for hbot are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denies Hyperbaric Oxygen Therapy as Experimental — and Why You Can Appeal

UnitedHealthcare's coverage policy for hyperbaric oxygen therapy (HBOT) distinguishes between indications it considers covered (sometimes called "established" uses) and those it designates as experimental, investigational, or unproven. UHC covers HBOT for a defined list of conditions; if your diagnosis falls outside that list — or if the reviewer applied the wrong policy category — an experimental denial may result.

This denial is not always correct. HBOT has FDA clearance as a medical device, and the Undersea and Hyperbaric Medical Society (UHMS) maintains a published list of approved indications based on clinical evidence. If your condition appears on the UHMS approved-indications list and matches UHC's covered list, the denial may reflect a documentation gap or a policy-application error rather than a genuine coverage exclusion.

## Your Federal Appeal Rights

• Internal appeal: ERISA §503 or applicable state law entitles you to a full-and-fair review. File within the period shown on your denial letter — commonly 180 days.
• External review: ACA §2719 provides independent external review after internal remedies are exhausted. File within approximately four months of final internal denial. Expedited review (typically a 72-hour turnaround) is available when delay poses serious health risk.

## Concrete Appeal Steps

1. Obtain UHC's current HBOT coverage policy — identify the list of covered indications and which category your condition falls into. 2. Confirm your treating physician's diagnosis code(s) and ensure the claim was submitted with the correct ICD code matching your covered condition. 3. Request the UHMS approved-indications list and confirm whether your condition appears on it. 4. Have your treating physician write a medical-necessity letter citing the specific indication, FDA clearance status of HBOT as a device, and relevant specialty-society support. 5. If UHC's policy excludes your indication but evidence supports coverage, submit a formal medical-exception request alongside the internal appeal. 6. Escalate to external review if the internal appeal is denied.

## Documentation to Gather

• Diagnosis confirmation with supporting records (specialist evaluation, imaging, lab results as applicable)
• Documentation of the specific HBOT indication and how it maps to UHC's covered-indication list
• Reference to UHMS approved-indications list (cited generically; do not quote statistics)
• FDA device clearance documentation for HBOT chambers (available from FDA website)
• Treating physician medical-necessity letter with clinical rationale for HBOT
• Records of prior treatments that have been tried and their outcomes, demonstrating why HBOT is now indicated

## Criteria-Mapping Structure

Build the appeal around two parallel columns: (1) UHC's experimental-determination basis, drawn verbatim from the denial letter and policy, and (2) the rebuttal evidence for each point — FDA clearance, UHMS indication status, treating physician's clinical rationale, and the patient's specific diagnostic and treatment history. This structure forces the reviewer to address each point individually and makes it difficult to sustain a blanket experimental determination.